Enhanced Bone Healing in Tibial Osteogenesis Using the Distraction Holiday Protocol in Ilizarov Fixation
Pappu Rajasekhar1, Tarun Jayakumar1, Praharsha Mulpur1
1Sunshine Bone and Joint Institute, KIMS-Sunshine Hospitals, Hyderabad, India.
Purpose:
This study aimed to evaluate the outcomes and complications of a new distraction holiday technique, to optimize and shorten regenerate healing in patients treated with Ilizarov fixation for critical tibial bone defects.
Methods:
This prospective observational study included patients who underwent Ilizarov fixation for critically sized tibial defects (> 6 cm) due to varying etiologies at a tertiary care center between 2018 and 2023 with a minimum 2-year follow-up. All patients underwent a single corticotomy and followed the same distraction protocol with 10 days of distraction (1 mm/day) followed by 4 days of holiday phase in a repeating sequence until the desired length was achieved. Functional outcomes, healing indices and complications were assessed.
Results:
Nine patients with a mean age of 29.67 (SD = 14.21) years and mean post-op length of distraction of 8.05 cm were evaluated. Patients had a mean distraction duration and total external fixation time of 112.22 (SD = 38.28) and 297.56 (SD = 68.25) days, respectively. The modified bone healing index (37.82 days) and regenerate consolidation index (32.99 days) was significantly less than expected by 31.03% (SD = 11.5). Majority of the patients (N = 6, 66.7%) had excellent ASAMI bone and function score. 6 (66.7%) patients reported pin-tract infections. None of the patients had residual infection and there was no incidence of any refractures.
Conclusion:
The study demonstrated reduced bone healing index and regenerate consolidation index with this distraction holiday technique in managing tibial bone defects alongside high-quality regenerate formation and satisfactory functional outcomes. The study, however, acknowledges the limitations of a small sample size and heterogeneity of the patient population, suggesting the need for further trials to validate these findings.


